Shanghai General Healthy Information and Technology Co., Ltd. (605186.SS)
CNY 21.89
(-1.4%)
CNY 21.89
(-1.4%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 44.49 Million CNY | -27.02% |
| 2022 | 135.41 Million CNY | -2.53% |
| 2021 | 147.04 Million CNY | 20.15% |
| 2020 | 125.83 Million CNY | 4.08% |
| 2019 | 123.73 Million CNY | 16.07% |
| 2018 | 106.84 Million CNY | 22.62% |
| 2017 | 86.26 Million CNY | 48.91% |
| 2016 | 58.64 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 28.13 Million CNY | 952.69% |
| 2024 Q3 | -2.72 Million CNY | -106.26% |
| 2024 Q1 | 378.86 Thousand CNY | 112.72% |
| 2023 Q3 | -10.86 Million CNY | -120.83% |
| 2023 FY | - CNY | -27.02% |
| 2023 Q4 | 53.89 Million CNY | 596.23% |
| 2023 Q1 | 13.5 Million CNY | -62.11% |
| 2023 Q2 | 52.15 Million CNY | 286.06% |
| 2022 Q4 | 35.65 Million CNY | -23.34% |
| 2022 Q3 | 46.51 Million CNY | -17.51% |
| 2022 Q2 | 56.38 Million CNY | 311.9% |
| 2022 Q1 | 13.68 Million CNY | -77.58% |
| 2022 FY | - CNY | -2.53% |
| 2021 Q4 | 61.06 Million CNY | 115.76% |
| 2021 Q1 | 10.19 Million CNY | -81.02% |
| 2021 Q2 | 56.86 Million CNY | 457.7% |
| 2021 Q3 | 28.3 Million CNY | -50.23% |
| 2021 FY | - CNY | 20.15% |
| 2020 FY | - CNY | 4.08% |
| 2020 Q2 | 49.35 Million CNY | 585.37% |
| 2020 Q1 | 7.2 Million CNY | -90.03% |
| 2020 Q3 | 22.88 Million CNY | -53.63% |
| 2020 Q4 | 53.72 Million CNY | 134.75% |
| 2019 FY | - CNY | 16.07% |
| 2019 Q4 | 72.22 Million CNY | 2026.76% |
| 2019 Q2 | 24.34 Million CNY | 0.0% |
| 2019 Q1 | 24.34 Million CNY | 0.0% |
| 2019 Q3 | 3.39 Million CNY | -86.05% |
| 2018 FY | - CNY | 22.62% |
| 2017 FY | - CNY | 48.91% |
| 2016 FY | - CNY | 0.0% |